中国继续医学教育
中國繼續醫學教育
중국계속의학교육
CHINA CONTINUING MEDICAL EDUCATION
2015年
10期
259-260
,共2页
中西医结合%乙肝肝硬化%疗效
中西醫結閤%乙肝肝硬化%療效
중서의결합%을간간경화%료효
Combine traditional Chinese and western medicine%Hepatitis B cirrhosis of the liver%Curative effect
目的:微探讨分析中西医结合治疗乙肝肝硬化的疗效。方法选取本院2012~2013年间收治的80例乙肝肝硬化患者,随机分为对照组和观察组,每组各40例。对照组给予恩替卡韦治疗,观察组在对照组基础上给予柔肝散结汤治疗,比较两组观察指标。结果治疗后两组的肝功能积分下降,P>0.05,差异不具有统计学意义;治疗后两组的血清肝纤维化指标下降,与对照组比较,观察组HA和PC-Ⅲ明显降低,P<0.05,差异具有统计学意义;两组治疗后的HBV-DNA阴转率比较,P>0.05,差异不具有统计学意义。两组治疗后的TBIL复常率比较,P<0.05,差异具有统计学意义。结论中西医结合恩替卡韦联合柔肝散结汤治疗乙肝肝硬化的疗效显著,可改善肝功能和预后。
目的:微探討分析中西醫結閤治療乙肝肝硬化的療效。方法選取本院2012~2013年間收治的80例乙肝肝硬化患者,隨機分為對照組和觀察組,每組各40例。對照組給予恩替卡韋治療,觀察組在對照組基礎上給予柔肝散結湯治療,比較兩組觀察指標。結果治療後兩組的肝功能積分下降,P>0.05,差異不具有統計學意義;治療後兩組的血清肝纖維化指標下降,與對照組比較,觀察組HA和PC-Ⅲ明顯降低,P<0.05,差異具有統計學意義;兩組治療後的HBV-DNA陰轉率比較,P>0.05,差異不具有統計學意義。兩組治療後的TBIL複常率比較,P<0.05,差異具有統計學意義。結論中西醫結閤恩替卡韋聯閤柔肝散結湯治療乙肝肝硬化的療效顯著,可改善肝功能和預後。
목적:미탐토분석중서의결합치료을간간경화적료효。방법선취본원2012~2013년간수치적80례을간간경화환자,수궤분위대조조화관찰조,매조각40례。대조조급여은체잡위치료,관찰조재대조조기출상급여유간산결탕치료,비교량조관찰지표。결과치료후량조적간공능적분하강,P>0.05,차이불구유통계학의의;치료후량조적혈청간섬유화지표하강,여대조조비교,관찰조HA화PC-Ⅲ명현강저,P<0.05,차이구유통계학의의;량조치료후적HBV-DNA음전솔비교,P>0.05,차이불구유통계학의의。량조치료후적TBIL복상솔비교,P<0.05,차이구유통계학의의。결론중서의결합은체잡위연합유간산결탕치료을간간경화적료효현저,가개선간공능화예후。
Objective To study the analysis of combining traditional Chinese and western medicine treatment the curative effect of hepatitis b cirrhosis of the liver.MethodsSelected 80 cases treated in our hospital from 2012 to 2012 hepatitis b patients with cirrhosis, randomly divided into control group and observation group, 40 cases in each group. Control group given entecavir treatment, the observation group in the control group given on the basis of liver ifghts soup treatment, compared two groups to observe. ResultsTwo groups after treatment of liver function integral,P>0.05, In the two groups after treatment serum liver fibrosis indexes decreased, compared with the control group and observation group of HA and PC-Ⅲsigniifcantly decreased,P<0.05 was statistically signiifcant, The two groups after treatment of HBV - DNA Yin turn rate,P>0.05 comparable. The two groups after treatment of TBIL complex, often rate,P<0.05 was statistically signiifcant.Conclusion Combines traditional Chinese and western medicine entecavir combined liver fights soup of hepatitis b cirrhosis of the liver with obvious therapeutic effect, can improve liver function and prognosis, worthy of clinical popularization and application..